ArticleFrontiers in oncology2021

Vemurafenib Combined With Trametinib Significantly Benefits the Survival of a Patient With Stage IV Pancreatic Ductal Adenocarcinoma With BRAF V600E Mutation: A Case Report.

Ziyao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.